Trade National Research Corp - NRC CFD

National Research Company profile

About National Research Corporation

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare organizations in the United States and Canada. The Company’s purpose is to enable human understanding. Its solutions enable healthcare organizations to understand what matters most to each person they serve. The Company’s portfolio of solutions represents a set of capabilities that individually and collectively provide value to its clients. The Company’s portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. Its clients include integrated health systems, post-acute providers and payer organizations.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, National Research Corporation revenues increased 11% to $148M. Net income applicable to common stockholders increased 1% to $37.4M. Revenues reflect United States segment increase of 11% to $145M. Net income was partially offset by Selling, general and administrative, ex increase of 19% to $36.3M (expense), Other, Net decrease of 99% to $4K (income).

Equity composition

Common Stock $.001 Par, 04/11, 20M auth., 8,091,985 issd., less 1,378,578 shs. in Treas. @ $22.9M. Insiders own 67.65%. IPO: 10/97, 2.1M shares (1.25M by the Company) @ $15 by William Blair & Company.